1. New cyclophilin inhibitors unrelated to cyclosporine potently inhibit HCV replication and revert HCV-induced mitochondrial dysfunction;Ahmed-Belkacem;Hepatology,2012
2. Alisporivir (ALV) plus PEG-interferon/ribavirin (PR) in HCV G1 treatment-experienced patients achieves primary endpoint with superior efficacy at treatment week 12 compared to retreatment with PR;Alberti;Journal of Hepatology,2012
3. Inhibition of cyclophilins alters lipid trafficking and blocks hepatitis C virus secretion;Anderson;Virol. J.,2011
4. Fluvastatin inhibits hepatitis C replication in humans;Bader;American Journal of Gastroenterology,2008
5. New treatments for influenza;Barik;BMC Med.,2012